Ji Hoon Han is a Doctoral Student at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) since January 2020, specializing in computational biology. Previously, Ji Hoon worked as a Data Analyst in the oncological field at CHUV | Lausanne University Hospital from December 2018 to December 2019, focusing on cancer genomics. Ji Hoon's research experience includes roles as an Associate Researcher at EPFL, a Research Associate at Université de Genève, a Research Assistant at Korea University, and an internship at GE Healthcare. Academic qualifications include a PhD in Computational Biology from the University of Basel, an MSc in Bioinformatics from the University of Geneva, and a BSc in Bioengineering and Biomedical Engineering from Cardiff University, where Ji Hoon also held the position of President of the Korean Society.
This person is not in any offices
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to advance the understanding of vision, its diseases and to develop new therapies for vision loss. The institute is constituted as a foundation. IOB started operations in 2018. At IOB, we accelerate the conversion of basic research into innovative treatments which change the field of ophthalmic therapy. Interdisciplinary teams of researchers and clinicians work hand in hand. These problem-solvers and innovators have in-depth knowledge of unmet medical needs, and daily exposure to patients. Together, they improve the understanding of vision, and of the cells involved in eye disease. In this highly collaborative environment, IOB turns discoveries and technologies into clinical benefits for patients with blinding conditions. We help advance the practice of ophthalmic disease based on the genetic, structural and functional understanding of the cell types and their interactions within the human eye. At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to advance the understanding of eye diseases and to develop new therapies for vision loss.